Standard Biotools Inc. (LAB): Revenue
$85.33M
Year ended 2025-12-31
$84.60M
Trailing 12 months to 2026-06-30
-4.5%
3-year compound annual growth
-9.2%
5-year compound annual growth
-2.9%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $85.33M | -6.2% | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | $91.01M | -14.4% | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | $106.34M | +8.6% | 2026-03-16, From 2023-01-01 |
| 2022-12-31 | $97.95M | -25.0% | 2025-03-11, From 2022-01-01 |
| 2021-12-31 | $130.58M | -5.5% | 2023-03-14, From 2021-01-01 |
| 2020-12-31 | $138.14M | +17.8% | 2022-03-08, From 2020-01-01 |
| 2019-12-31 | $117.24M | +3.8% | 2022-03-08, From 2019-01-01 |
| 2018-12-31 | $112.96M | +10.8% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $101.94M | -2.4% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $104.45M | -8.9% | 2019-03-18, From 2016-01-01 |
| 2015-12-31 | $114.71M | -1.5% | 2018-03-08, From 2015-01-01 |
| 2014-12-31 | $116.46M | +63.6% | 2017-03-03, From 2014-01-01 |
| 2013-12-31 | $71.18M | +36.0% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $52.33M | +22.1% | 2015-02-26, From 2012-01-01 |
| 2011-12-31 | $42.87M | +27.7% | 2014-03-12, From 2011-01-01 |
| 2010-12-31 | $33.56M | +32.1% | 2013-03-12, From 2010-01-01 |
| 2009-12-31 | $25.41M | n/a | 2012-03-26, From 2009-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Standard Biotools Inc. (LAB) | 2025-12-31 | $85.33M | -6.2% |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | $84.28M | -5.5% |
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | $83.98M | +54.0% |
| Cytokinetics Inc (CYTK) | 2025-12-31 | $88.04M | +376.6% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $82.03M | -46.1% |
| ADC Therapeutics SA (ADCT) | 2025-12-31 | $81.36M | +14.9% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $79.95M | +104.9% |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $94.57M | -31.8% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $76.20M | -44.8% |
Compare LAB, SPRY, NRIX, CYTK side by side · Screen every company in Pharmaceutical Preparations ↗